Altaris’ most common sectors for investment aremedical products (34%) and life science (24%) . The Firm’s most common investment types include growth capital (21%) and buyout (lbo, mbo, mbi) (18%). In total, Altaris has invested in 17 US states and 4 different countries.
Sign-up to view Altaris’ full profile and discover more mega-sized private equity firm investors just like it.
10 East 53rd Street, 31st Floor,
New York City,
New York
10022
United States
(212) 931-0250
www.altariscap.com
info@altariscap.com
| Status | Dates | Company | Description | |||||
|---|---|---|---|---|---|---|---|---|
| Investment | Exit | |||||||
| Current | 2024-12-25 | - |
WuXi AppTec - Advanced Therapies
Life Science Shanghai, China |
WuXi AppTec's Advanced Therapies offers customers a complete cell therapy outsourcing solution, including viral vector manufacturing, cell therapy process development and manufacturing, and biosafety testing.
|
||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
